This post has been archived and contains information that may be out of date.
The United States Pharmacopeia (USP) has released newly revised standards to assist health care practitioners in consistently producing high-quality compounded medicines that are the right strength and free of contaminants. The final USP 797, USP 825, and USP 795 and General Chapter 800 standards will take effect Dec. 1.
CHA, the CHA Medication Safety Committee, hospital members, and other association and regulatory partners have actively engaged over the past several years to improve sterile compounding processes, facility reconstruction or renovation, and related education to meet both USP standards and state Board of Pharmacy laws and regulations.
Assembly Bill 973 (Irwin, D-Thousand Oaks), which is moving through the current legislative session, would align California Board of Pharmacy statute and regulations with USP standards.
